Well at least there might be a slim chance. For example, Gilbert Syndrome is a generally inherited condition in which the liver has a lower level of an enzyme that processes bilirubin, so a person's bilirubin blood levels are generally higher than the normal range, a little higher, moderately higher, or much higher. Moderate increases generally don't cause any problem and there's no pathology of the liver. Reportedly it can cause fatigue, perhaps related to lower levels of platelets, perhaps a yellow jaundice pigmentation with higher levels. But numerous studies found that those with Gilbert syndrome have 40% lower overall mortality, and lower cancer and cardiovascular mortality. So if some environmental factor could create Gilbert syndrome in people it might extend their lifespans. Of course, I don't see Big Pharma looking to create a drug to inhibit the enzyme and thus raise unconjugated bilirubin, which is also a potent antioxidant.
But I think they could make money with that drug if people thought it could extend their lifespan. Then they could create another drug to counteract the side effects in case it caused any, so people could still take it for it benefits. I've seen a lot of those secondary drugs to counteract side effects lately. Quite a racket.
Slim to none!
Well at least there might be a slim chance. For example, Gilbert Syndrome is a generally inherited condition in which the liver has a lower level of an enzyme that processes bilirubin, so a person's bilirubin blood levels are generally higher than the normal range, a little higher, moderately higher, or much higher. Moderate increases generally don't cause any problem and there's no pathology of the liver. Reportedly it can cause fatigue, perhaps related to lower levels of platelets, perhaps a yellow jaundice pigmentation with higher levels. But numerous studies found that those with Gilbert syndrome have 40% lower overall mortality, and lower cancer and cardiovascular mortality. So if some environmental factor could create Gilbert syndrome in people it might extend their lifespans. Of course, I don't see Big Pharma looking to create a drug to inhibit the enzyme and thus raise unconjugated bilirubin, which is also a potent antioxidant.
Yes, I'm afraid that Big Pharma and much of the Medical establishment, is more concerned with making money than helping save people's lives
But I think they could make money with that drug if people thought it could extend their lifespan. Then they could create another drug to counteract the side effects in case it caused any, so people could still take it for it benefits. I've seen a lot of those secondary drugs to counteract side effects lately. Quite a racket.